AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer
A Multicenter Observational Study to Develop and Validate a Deep Learning Model for Dynamic Assessment of Postoperative Bleeding Risk to Assist Re-operation Decision-Making in Patients With Gastric Cancer
1 other identifier
observational
7,000
1 country
1
Brief Summary
The goal of this observational study is to develop and validate a deep learning model to dynamically assess postoperative bleeding risk and assist in decision-making for re-operation in adult patients (≥18 years) diagnosed with primary gastric cancer undergoing radical gastrectomy. The main question\[s\] it aims to answer \[is/are\]: Can an AI model based on perioperative dynamic physiological parameters and precise intraoperative blood loss accurately predict the risk of postoperative bleeding requiring re-operation? Does the application of this AI model improve clinical decision-making (e.g., earlier warning time, optimal intervention timing) and patient outcomes (e.g., mortality, length of stay)? Since there is no comparison group (this is a pure observational study without intervention arms), researchers will not compare different treatment groups. Instead, the investigators will evaluate the model's performance (sensitivity, negative predictive value, AUC, calibration) using retrospective data for training and prospective multi-center data for external validation. Participants will: Undergo standard radical gastrectomy and routine postoperative care as per clinical practice (no study-specific interventions). Have their perioperative data collected, including demographics, medical history, vital signs, laboratory tests (blood gas analysis), surgical details, and precise intraoperative blood loss measurements. (For prospective participants only) Provide informed consent and complete follow-up assessments up to 30 days post-surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2026
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 10, 2026
CompletedStudy Start
First participant enrolled
April 10, 2026
CompletedFirst Posted
Study publicly available on registry
April 13, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
January 31, 2028
April 13, 2026
March 1, 2026
1.7 years
March 10, 2026
April 7, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
predictive performance of the deep learning model for identifying patients at high risk of postoperative bleeding requiring re-operation
The Area Under the Receiver Operating Characteristic Curve (AUC-ROC) of the AI model for predicting postoperative bleeding requiring re-operation in the external validation cohort.
The primary endpoint is the AUC-ROC of the model in predicting postoperative bleeding requiring re-operation within 30 days after surgery
Study Arms (3)
Training set (led by the Principal Investigator)
The main part of retrospective data for model construction, parameter learning, without interventions
Validation set (led by the Principal Investigator)
The remainder of the retrospective data for hyperparameter tuning to prevent overfitting, without interventions
External validation set (conducted by other investigators)
Prospective collected data for final performance evaluation, without interventions
Eligibility Criteria
This study includes adults (≥18y) with confirmed primary gastric cancer undergoing elective radical gastrectomy (proximal/distal/total) with D1+/D2 lymphadenectomy at \[Center\]. The cohort comprises retrospective (\[2015.6\]-\[2026.2\]) and prospective (\[2026.3\]-present) arms. Emergency, palliative, or multi-organ resections are excluded to ensure homogeneity. The investigators anticipate enrolling 7000 patients. The primary outcome is postoperative hemorrhage requiring surgical re-intervention within 30 days. Estimated incidence is 0.5%-2.0%. To address this class imbalance, the AI model will employ stratified sampling and cost-sensitive learning.This population represents standard candidates for curative surgery in tertiary centers. By excluding extreme cases, the model is optimized for risk stratification in routine elective settings, where early warnings prevent catastrophic outcomes. Prospective data will validate real-time generalizability.
You may qualify if:
- Age: Patients aged ≥ 18 years.
- Diagnosis: Histologically confirmed primary gastric cancer.
- Surgical Procedure: Underwent radical gastrectomy (including proximal, distal, or total gastrectomy).
- Consent: Provision of written informed consent (required specifically for the prospective phase).
- Data Completeness: Availability of complete preoperative clinical data and postoperative follow-up records covering at least the first 15 days post-surgery.
- Oncological History: No history of other primary malignant tumors.
You may not qualify if:
- Surgical Type: Patients who underwent non-radical resection or emergency surgery.
- Data Quality: Missing rate of key data fields exceeds 20%.
- Preoperative Condition: Presence of severe preoperative infection or organ failure.
- Follow-up Compliance: Unwillingness to participate in prospective follow-up or inability to complete the follow-up schedule (applicable only to the prospective phase).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The First Affiliated Hospital, Zhejiang University School of Medicine Yuhang Campus
Hangzhou, Zhejiang, 330100, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jichao Qin, M.D.
Zhejiang University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- OTHER
- Target Duration
- 30 Days
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 10, 2026
First Posted
April 13, 2026
Study Start
April 10, 2026
Primary Completion (Estimated)
December 31, 2027
Study Completion (Estimated)
January 31, 2028
Last Updated
April 13, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share